News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

“GI Talk”: A Review of Data from the ASCO 2020 Virtual Meeting

EP. 1: Colorectal Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

EP. 2: Gastric Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

EP. 3: Liver Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

EP. 4: Pancreatic Cancer Updates

ByYelena Y. Janjigian, MD, Memorial Sloan Kettering Cancer Center,Jaffer A. Ajani, MD, MD Anderson Cancer Center,Daniel Catenacci, MD, University of Chicago Medicine,Zev A. Wainberg, MD, UCLA Medical Center

August 10th 2020

Trending on OncLive

Epcoritamab Significantly Improves PFS Vs Chemoimmunotherapy in R/R Large B-Cell Lymphoma

MONUMENTAL-3 Data Support Talquetamab Plus Daratumumab ± Pomalidomide as a New SOC in R/R Myeloma

Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis

AJ1-11095 Shows Spleen Responses and Symptom Improvement in Post–Type I JAK Inhibitor Myelofibrosis

FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC